Jessica Vamathevan, PhD, is the Head of Strategy at EMBL-EBI, based at EMBL-EBI in Hinxton. Her educational background covers Medical Science, Bioinformatics, and Computer Science. Prior to her current role, she held several positions at GSK, including Operations Director for Open Targets, overseeing informatics and experimental target validation projects. Jessica also served as a Team Leader in GSK Computational Biology, collaborating with discovery scientists on impactful bioinformatics projects in various therapeutic areas, including infectious diseases, respiratory, immuno-inflammation, and rare diseases, with a particular focus on drug discovery ML application.